PubMed ClinicalTrials.gov
These drugs are primarily approved for treating type 2 diabetes, so coverage is usually only available if a patient with PCOS also has type 2 diabetes or obesity as a related condition
GLP-1 therapy isnt just about weight loss, its about creating healthier habits that last
Bodily introduction of any kind into humans or animals is strictly forbidden by law
Summary table of pivot efficiency In published trials, the difference between retatrutide, tirzepatide, and semaglutide is significant: switching from semaglutide to retatrutide nearly doubles the average weight loss
At 48 weeks, for example, retatrutide had reduced levels of triglycerides by up to 40.6% , and levels of a protein called apoC-III involved in glucose metabolism and inflammation by 38%